These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 14978154)

  • 1. Sympathetic hyperactivity in chronic renal failure: a wake-up call.
    Koomans HA; Blankestijn PJ; Joles JA
    J Am Soc Nephrol; 2004 Mar; 15(3):524-37. PubMed ID: 14978154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cause and consequences of sympathetic hyperactivity in chronic kidney disease.
    Kotanko P
    Blood Purif; 2006; 24(1):95-9. PubMed ID: 16361848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Moxonidine normalizes sympathetic hyperactivity in patients with eprosartan-treated chronic renal failure.
    Neumann J; Ligtenberg G; Oey L; Koomans HA; Blankestijn PJ
    J Am Soc Nephrol; 2004 Nov; 15(11):2902-7. PubMed ID: 15504943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Causes and consequences of increased sympathetic activity in renal disease.
    Joles JA; Koomans HA
    Hypertension; 2004 Apr; 43(4):699-706. PubMed ID: 14981063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sympathetic nervous system and chronic renal failure.
    Boero R; Pignataro A; Ferro M; Quarello F
    Clin Exp Hypertens; 2001; 23(1-2):69-75. PubMed ID: 11270590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Losartan reduces sympathetic nerve outflow from the brain of rats with chronic renal failure.
    Campese VM; Ye S; Truong RH; Gamburd M
    J Renin Angiotensin Aldosterone Syst; 2000 Jun; 1(2):202-8. PubMed ID: 11967814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enalapril and losartan reduce sympathetic hyperactivity in patients with chronic renal failure.
    Klein IH; Ligtenberg G; Oey PL; Koomans HA; Blankestijn PJ
    J Am Soc Nephrol; 2003 Feb; 14(2):425-30. PubMed ID: 12538743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sympathetic hyperactivity in chronic kidney disease.
    Blankestijn PJ
    Nephrol Dial Transplant; 2004 Jun; 19(6):1354-7. PubMed ID: 15069180
    [No Abstract]   [Full Text] [Related]  

  • 9. Sympathetic hyperactivity and clinical outcome in chronic kidney disease patients during standard treatment.
    Penne EL; Neumann J; Klein IH; Oey PL; Bots ML; Blankestijn PJ
    J Nephrol; 2009; 22(2):208-15. PubMed ID: 19384838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of sympathetic nervous activity in renal injury and end-stage renal disease.
    Masuo K; Lambert GW; Esler MD; Rakugi H; Ogihara T; Schlaich MP
    Hypertens Res; 2010 Jun; 33(6):521-8. PubMed ID: 20339374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sympathetic overactivity and the kidney].
    Habicht A; Watschinger B
    Wien Klin Wochenschr; 2003 Sep; 115(17-18):634-40. PubMed ID: 14603734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Excessive sympathetic activation in heart failure with chronic renal failure: role of chemoreflex activation.
    Despas F; Detis N; Dumonteil N; Labrunee M; Bellon B; Franchitto N; Galinier M; Senard JM; Pathak A
    J Hypertens; 2009 Sep; 27(9):1849-54. PubMed ID: 19542895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure.
    Ligtenberg G; Blankestijn PJ; Oey PL; Klein IH; Dijkhorst-Oei LT; Boomsma F; Wieneke GH; van Huffelen AC; Koomans HA
    N Engl J Med; 1999 Apr; 340(17):1321-8. PubMed ID: 10219067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sympathetic activation in chronic renal failure.
    Schlaich MP; Socratous F; Hennebry S; Eikelis N; Lambert EA; Straznicky N; Esler MD; Lambert GW
    J Am Soc Nephrol; 2009 May; 20(5):933-9. PubMed ID: 18799718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tonic chemoreflex activation contributes to the elevated muscle sympathetic nerve activity in patients with chronic renal failure.
    Hering D; Zdrojewski Z; Król E; Kara T; Kucharska W; Somers VK; Rutkowski B; Narkiewicz K
    J Hypertens; 2007 Jan; 25(1):157-61. PubMed ID: 17143187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sympathetic overactivity and arterial hypertension in renal failure.
    Orth SR; Amann K; Strojek K; Ritz E
    Nephrol Dial Transplant; 2001; 16 Suppl 1():67-9. PubMed ID: 11369825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sympathetic hyperactivity--a hidden enemy in chronic kidney disease patients.
    Blankestijn PJ
    Perit Dial Int; 2007 Jun; 27 Suppl 2():S293-7. PubMed ID: 17556322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sympathetic overactivity as a cause of hypertension in chronic renal failure.
    Augustyniak RA; Tuncel M; Zhang W; Toto RD; Victor RG
    J Hypertens; 2002 Jan; 20(1):3-9. PubMed ID: 11791019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of renal denervation on cardiac oxidative stress and local activity of the sympathetic nervous system and renin-angiotensin system in acute myocardial infracted dogs.
    Feng Q; Lu C; Wang L; Song L; Li C; Uppada RC
    BMC Cardiovasc Disord; 2017 Feb; 17(1):65. PubMed ID: 28212603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sympathetic hyperactivity and cardiac dysfunction post-MI: different impact of specific CNS versus general AT1 receptor blockade.
    Huang BS; Ahmad M; Tan J; Leenen FH
    J Mol Cell Cardiol; 2007 Oct; 43(4):479-86. PubMed ID: 17714732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.